Liu Kangyu, Chen Yu, Meng Yunlong, Wang Xinyao, Tang Xingkun, Li Haining, Chen Jianjun, Zhong Zilin
Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Department of Pediatrics, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China.
Institute of Medical Genetics, Department of Big Data in Health Science School of Public Health and General Practice Medicine, Tongji University School of Medicine, Tongji University, Shanghai, 200331, China.
Hum Genomics. 2025 Jun 28;19(1):72. doi: 10.1186/s40246-025-00782-1.
Pontocerebellar hypoplasia type 11 (PCH11) is an autosomal recessive disorder caused by variants in TBC1D23. The molecular basis for its clinical heterogeneity remains poorly understood. Here, we identified a novel TBC1D23 variant in a Chinese family, investigated its underlying pathogenic mechanisms, and systematically reviewed the clinical phenotypes of all reported cases of PCH11.
We identified a novel homozygous frameshift variant, c.511_512delTT (p.F171Qfs*8), in TBC1D23. The patient exhibited a severe phenotype, including marked pontocerebellar hypoplasia, a thinned corpus callosum, global developmental delay, and severe language and motor impairments. Mechanistic studies in a zebrafish model revealed that the mutant transcript partially escaped nonsense-mediated decay (NMD), with expression levels at approximately 50% of the wild-type. In vitro, the resultant truncated protein showed enhanced stability and aberrant cytoplasmic distribution instead of its normal Golgi localization. Furthermore, its expression significantly inhibited cell proliferation.
Our study identifies c.511_512delTT as a novel pathogenic variant in TBC1D23. We propose the severe phenotype stems from a primary loss-of-function (LoF), which is likely exacerbated by the cytotoxic effect of the truncated protein produced via partial NMD escape. Our findings suggest this mutant protein exhibits increased stability. This model provides a novel explanation for the phenotypic heterogeneity in PCH11 and expands the mutational spectrum of this disorder.
11型脑桥小脑发育不全(PCH11)是一种由TBC1D23基因变异引起的常染色体隐性疾病。其临床异质性的分子基础仍知之甚少。在此,我们在中国一个家系中鉴定出一种新的TBC1D23变异,研究了其潜在的致病机制,并系统回顾了所有已报道的PCH11病例的临床表型。
我们在TBC1D23中鉴定出一种新的纯合移码变异,即c.511_512delTT(p.F171Qfs*8)。该患者表现出严重的表型,包括明显的脑桥小脑发育不全、胼胝体变薄、全面发育迟缓以及严重的语言和运动障碍。斑马鱼模型的机制研究表明,突变转录本部分逃避了无义介导的衰变(NMD),其表达水平约为野生型的50%。在体外,产生的截短蛋白显示出增强的稳定性和异常的细胞质分布,而不是正常的高尔基体定位。此外,其表达显著抑制细胞增殖。
我们的研究确定c.511_512delTT是TBC1D23中的一种新的致病变异。我们认为严重表型源于原发性功能丧失(LoF),通过部分NMD逃避产生的截短蛋白的细胞毒性作用可能会使其加剧。我们的发现表明这种突变蛋白具有更高的稳定性。该模型为PCH11的表型异质性提供了一种新的解释,并扩展了该疾病的突变谱。